People: Vical Inc (VICL.O)

VICL.O on Nasdaq

3.50USD
24 May 2013
Price Change (% chg)

$-0.08 (-2.23%)
Prev Close
$3.58
Open
$3.55
Day's High
$3.61
Day's Low
$3.49
Volume
455,394
Avg. Vol
660,627
52-wk High
$4.74
52-wk Low
$2.61

Search Stocks

Smith, Larry 

Brief Biography

Dr. Larry R. Smith, Ph.D., is Vice President - Vaccine Research of Vical Inc. He joined the company as Executive Director, Vaccinology in September 2003, and was named Vice President, Vaccine Research in October 2006. Prior to joining Vical, Dr. Smith was Director of Viral Vaccines Research at Wyeth Vaccines, where he oversaw the immunogenicity testing of various viral vaccines including a number of recombinant viral vectors. Prior to joining Wyeth in 1996, Dr. Smith was a Scientific Investigator at Immune Response, where he identified autoreactive T-cell targets in psoriasis and multiple sclerosis which led to the clinical testing of several therapeutic vaccine candidates. Dr. Smith received a B.S. degree in Biology from Purdue University, a Ph.D. in Microbiology and Immunology from the University of Texas Medical Branch, and was a postdoctoral fellow in the Immunology Department at Scripps Clinic and Research Foundation.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Search Stocks